Meeting Banner
Abstract #4181

Evaluation of Secondary Prevention Effectiveness of Ginkgo Biloba Extract (EGb 761) in Acute Ischemic Stroke by QSM and Venous Oxygen Saturation

Wen-Ting Lan1, Yue-Fei Wu2, Hui Zhang1, Xin-Zhong Ruan1, Yi Huang3, Xiao-Jing Li4, and Yunzhu Wu5
1Department of Radiology, Ningbo First Hospital, Ningbo Hospital of Zhejiang University, Ningbo, China, 2Department of Neurology, Ningbo First Hospital, Ningbo, China, 3Department of Neurosurgery, Ningbo First Hospital, Ningbo, China, 4Department of Gerontology, Ningbo First Hospital, Ningbo, China, 5MR Scientific Marketing, SIEMENS Healthineers, Shanghai, China


In this study, we applied quantitative susceptibility mapping (QSM) and venous oxygen saturation measurement in acute ischemic stroke patients who took ginkgo biloba extract (EGb 761) treatment. EGb 761’s secondary prevention effectiveness of ischemic stroke patients with cerebral microbleeds was similar to Aspirin. Furthermore, Ginkgo biloba extract could not only improve neuroprotective efficiency and prognosis by increasing oxygen saturation of the vein near infarction, but also could reduce the incidence of adverse side effects such as gastrointestinal ulcers and bleeding usually caused by Aspirin.

This abstract and the presentation materials are available to members only; a login is required.

Join Here